New Triglucored Forte Tablet
New Triglucored Forte Tablet is a combination antidiabetic medicine used to treat type 2 diabetes mellitus in adults. It helps control high blood sugar levels and reduces the risk of diabetes-related complications.
Uses:
- Treatment of Type 2 diabetes mellitus
Benefits:
- Lowers blood glucose levels by improving insulin sensitivity and reducing glucose production.
- Helps remove excess glucose from the body through urine.
- Prevents complications of diabetes such as kidney damage, nerve problems, eye damage, and limb loss.
- Works best when combined with a healthy diet, regular exercise, and weight management.
How it works:
New Triglucored Forte Tablet combines three medicines:
- Glibenclamide: Increases insulin secretion from the pancreas to lower blood sugar.
- Metformin: Reduces glucose production in the liver, delays glucose absorption from the intestines, and improves insulin sensitivity.
- Pioglitazone: Enhances insulin sensitivity to help the body use glucose more effectively.
How to use:
- Take as prescribed by your doctor, usually with food.
- Swallow the tablet whole; do not chew, crush, or break it.
- Take it at the same time each day for consistent blood sugar control.
- If a dose is missed, take it as soon as possible unless it’s almost time for your next dose. Do not double doses.
Side Effects:
Most side effects are mild and often resolve as your body adjusts. Consult your doctor if they persist.
- Hypoglycemia (low blood sugar), dizziness, sweating, headache, shakiness
- Nausea, vomiting, diarrhea, abdominal pain
- Weight gain, anemia, visual disturbances
- Erectile dysfunction, blood in urine
Safety Advice:
- Alcohol: Unsafe; increases risk of low blood sugar.
- Pregnancy: Consult your doctor; only use if benefits outweigh risks.
- Breastfeeding: Unsafe; may harm the baby.
- Driving: May affect concentration if symptoms occur.
- Kidney disease: Unsafe; avoid use.
- Liver disease: Use with caution; dose adjustment may be needed.
New Triglucored Forte Tablet is an effective option for managing type 2 diabetes when single or dual therapy is insufficient, helping maintain blood sugar within the target range and reducing long-term complications.



Reviews
There are no reviews yet.